2021
DOI: 10.1128/msphere.00567-21
|View full text |Cite
|
Sign up to set email alerts
|

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study

Abstract: The hemagglutination inhibition (HAI) assay is the most commonly used serology assay to detect antibodies from influenza vaccination or influenza virus infection. This assay has been used for decades but requires improved standardization of procedures to provide meaningful data.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 14 publications
(23 reference statements)
5
11
0
Order By: Relevance
“…The goal of the FLUCOP project is to have a direct and evidencebased impact on the quality of regulatory decisions and to provide valid and appropriate serological tools for the future definition of alternative correlates of protection for (novel) influenza vaccines. The consortium has made considerable progress with standardization of the HAI assay and Enzyme-Linked-Lectin Assay (ELLA) with large collaborative studies carried out and freely available published SOPs (2,3). Additionally collaborative studies to standardize the Microneutralization (MN) assay have also been carried out (manuscript in preparation).…”
Section: Introductionmentioning
confidence: 99%
“…The goal of the FLUCOP project is to have a direct and evidencebased impact on the quality of regulatory decisions and to provide valid and appropriate serological tools for the future definition of alternative correlates of protection for (novel) influenza vaccines. The consortium has made considerable progress with standardization of the HAI assay and Enzyme-Linked-Lectin Assay (ELLA) with large collaborative studies carried out and freely available published SOPs (2,3). Additionally collaborative studies to standardize the Microneutralization (MN) assay have also been carried out (manuscript in preparation).…”
Section: Introductionmentioning
confidence: 99%
“…The FLUCOP collaborative (Waldock et al) recently reported similar reductions in interlaboratory variation through the use of a consensus protocol and common critical reagents ( 10 ). This group also demonstrated that the use of a pooled postvaccinated human serum pool as a reference standard provided similar reductions in interlaboratory variation when different protocols and reagents are used.…”
Section: Discussionmentioning
confidence: 98%
“…Interestingly, Waldock et al demonstrated no cumulative reduction in interlaboratory variation when using a consensus protocol, common critical reagents, and a reference standard ( 10 ). They suggest that the improvements in assay performance obtained either through the use of a consensus protocol and common reagents or the use of a reference standard, are close to the limits of improvement possible.…”
Section: Discussionmentioning
confidence: 99%
“…However, as this model becomes more commonly employed in laboratories worldwide, there is a pressing need to capture the level of variability and heterogeneity intrinsic to this research. Cross-laboratory exercises have been employed in the past to evaluate the reproducibility of assays employed for influenza virus public health efforts (3)(4)(5)(6)44), but no such exercise has been performed to date evaluating influenza virus transmissibility in the ferret. In this exercise, 11 laboratories independently evaluated the ferret-to-ferret transmissibility of Cal/09 and ruddy turnstone/09 viruses that possess distinct transmission potential in humans.…”
Section: Discussionmentioning
confidence: 99%
“…These characterization efforts are undertaken by laboratories worldwide, employing zoonotic virus strains and experimental protocols that are similar but not uniform, which may lead to variation in the experimental results. To date, limited assessments of interlaboratory variability have been conducted for influenza virus serological assays (3)(4)(5)(6), but not for other in vitro or in vivo assays.…”
mentioning
confidence: 99%